This IDC Market Perspective provides IDC Health Insights' review of key IT deals, news, and digital initiatives in European life sciences and pharma in Q4 2019. In the evolving industry environment in Europe, it is critical for life sciences companies to closely follow the fast-moving trends and developments to promptly spot favorable opportunities and remain competitive. This is the sixth in the quarterly series of reports IDC Health Insights has released as it continues to provide in-depth research coverage of life sciences markets across Europe.
"European life sciences companies are exploring new ways to harness the potential of digital technology to offer innovative products and services that go beyond the traditional industry boundaries. Drug serialization and traceability regulatory requirements remain a major challenge for pharma supply chain actors, presenting significant opportunity for technology vendors targeting European markets, with opportunities extending beyond EU borders." — Senior Research Analyst Nino Giguashvili, IDC Health Insights Europe